Breaking News Instant updates and real-time market news.

RMBS

Rambus

$14.55

-0.2 (-1.36%)

, IIVI

II-VI

$43.45

0.75 (1.76%)

04:55
12/07/17
12/07
04:55
12/07/17
04:55

Barclays to hold a conference

Global Technology, Media & Telecommunications Conference is being held in San Francisco on December 6-7.

RMBS

Rambus

$14.55

-0.2 (-1.36%)

IIVI

II-VI

$43.45

0.75 (1.76%)

S

Sprint

$5.69

-0.05 (-0.87%)

YY

YY

$100.96

0.28 (0.28%)

CA

CA Technologies

$33.30

0.08 (0.24%)

CSCO

Cisco

$37.41

0.1 (0.27%)

FICO

Fair Isaac

$155.57

-0.02 (-0.01%)

T

AT&T

$36.11

-0.44 (-1.20%)

ORBK

Orbotech

$49.28

-0.16 (-0.32%)

INTU

Intuit

$156.19

1.72 (1.11%)

SPLK

Splunk

$80.45

2.44 (3.13%)

XLNX

Xilinx

$68.39

-0.03 (-0.04%)

AQ

Aquantia

$10.98

0.09 (0.83%)

APPN

Appian

$21.20

0.06 (0.28%)

DSGX

Descartes Systems

$26.45

-0.25 (-0.94%)

BOX

Box

$20.50

0.15 (0.74%)

JCOM

j2 Global

$74.85

-0.36 (-0.48%)

ZAYO

Zayo Group

$34.11

-0.31 (-0.90%)

WDAY

Workday

$102.35

3.15 (3.18%)

OTEX

OpenText

$32.18

-0.27 (-0.83%)

ELLI

Ellie Mae

$88.50

2.14 (2.48%)

NOW

ServiceNow

$117.76

1.56 (1.34%)

XRX

Xerox

$29.64

0.2 (0.68%)

  • 07

    Dec

  • 07

    Dec

  • 07

    Dec

  • 07

    Dec

  • 08

    Dec

  • 11

    Dec

  • 11

    Dec

  • 12

    Dec

  • 15

    Dec

  • 17

    Jan

  • 26

    Feb

RMBS Rambus
$14.55

-0.2 (-1.36%)

03/07/17
BNCH
03/07/17
NO CHANGE
Target $15
BNCH
Buy
Rambus license pact with Western Digital 'unique and intriguing,' says Benchmark
Benchmark analyst Gary Mobley called Rambus' (RMBS) newly-announced license agreement with Western Digital (WDC) "unique and intriguing," noting that Rambus memory patent licensing has historically been within the DRAM industry, not the NAND flash market. He believes the underpinnings of the agreement may relate to Rambus' ReRAM IP portfolio, and also finds it "interesting to note" that the agreement includes Rambus' security IP. Mobley has a Buy rating and $15 price target on Rambus shares.
10/24/17
LOOP
10/24/17
NO CHANGE
Target $19
LOOP
Buy
Rambus price target raised to $19 from $16 at Loop Capital
Loop Capital analyst Betsy Van Hees says Rambus is her Top 2018 Small Cap Idea, raising the price target on the stock to $19 and maintaining a Buy rating. Van Hees says the company's fixed royalty and licensing revenue, along with opportunities in the memory buffer and security businesses, position it for strong year-on-year earnings and revenue growth in FY18 and FY19.
09/22/17
JPMS
09/22/17
DOWNGRADE
Target $15
JPMS
Neutral
Rambus downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Paul Coster downgraded Rambus to Neutral citing a lack of catalysts following the company's analyst day. Coster still believes the shares are "somewhat undervalued" and keep a $15 price target on the name.
07/25/17
LOOP
07/25/17
NO CHANGE
Target $16
LOOP
Buy
Rambus undervalued with story still in early innings, says Loop Capital
Loop Capital analyst Betsy Van Hees said Rambus reported "a clean Q2 2017 beat across the board" and she noted that management said it believes Q3 revenue guidance and typical Q4 seasonal growth points to FY17 revenue slightly higher than the Street's consensus estimate. Van Hees, who sees Rambus as poised for strong earnings and revenue growth in 2017 and into 2018, believes the shares are undervalued and reiterates a Buy rating and $16 price target on the stock.
IIVI II-VI
$43.45

0.75 (1.76%)

08/08/17
BNCH
08/08/17
NO CHANGE
Target $44
BNCH
Buy
II-VI price target raised to $44 from $40 at Benchmark
Benchmark analyst Mark Miller noted II-VI beat expectations for earnings and revenue and he sees double digit growth opportunities for the company in several areas. He keeps a Buy rating on II-VI shares and raised his price target on the stock to $44 from $40.
11/01/17
NEED
11/01/17
NO CHANGE
Target $50
NEED
Buy
II-VI price target raised to $50 from $45 at Needham
Needham analyst James Ricchiuti raised his price target on II-VI to $50 after "solid" Q1 earnings showing 18% growth in Laser Solutions, 15% growth in Photonics, and 24% growth in Performance Products. Laser Solutions also helped the company increase its bookings by 3% on the year. The analyst maintains his Buy rating, noting that end markets appear healthy and 3D sensing is on track to ramp in the comping quarter.
11/13/17
NEED
11/13/17
NO CHANGE
Target $56
NEED
Buy
II-VI price target raised to $56 from $50 at Needham
Needham analyst James Ricchiuti raised his price target on II-VI to $56 after the company's investor day last week. Ricchiuti says that while the management did not break any new ground, it made a good investment case for areas with high-growth potential like 3D sensing for consumer applications and SiC substrates for wireless communications and power electronics. The analyst keeps his Buy rating, saying the company's management has a solid track record of identifying attractive growth opportunities in adjacent markets and driving shareholder value.
11/01/17
CHLM
11/01/17
NO CHANGE
Target $58
CHLM
Buy
II-VI price target raised to $58 from $50 at Craig-Hallum
Craig-Hallum analyst Richard Shannon raised his price target for II-VI to $58 from $50 following "strong" September quarter results. The analyst reiterates a Buy rating on the shares.
S Sprint
$5.69

-0.05 (-0.87%)

11/27/17
KEYB
11/27/17
NO CHANGE
Target $192
KEYB
Overweight
SBA Communications price target raised to $192 from $179 at KeyBanc
KeyBanc analyst Brandon Nispel raised his price target for SBA Communications (SBAC) to $192 from $179 to reflect potential contribution from Sprint (S) as well as his belief that FirstNet could also be a contributor in 2019. The analyst reiterates an Overweight rating on SBA Communications' shares.
12/05/17
COWN
12/05/17
NO CHANGE
Target $170
COWN
Outperform
SBA Communications price target raised to $170 from $155 at Cowen
Cowen analyst Colby Synesael raised his price target on SBA Communications (SBAC) to $170 from $155 following meetings with management. The analyst noted its opportunities with Sprint (S) and AT&T (T) along with the small likelihood of M&A. Synesael reiterated his Outperform rating on SBA Communications shares.
11/27/17
KEYB
11/27/17
NO CHANGE
Target $177
KEYB
Overweight
American Tower price target raised to $177 from $156 at KeyBanc
KeyBanc analyst Brandon Nispel raised his price target for American Tower (AMT) to $177 from $156 and raised his 2018 U.S. new leasing activity to reflect potential activity from Sprint (S). The analyst reiterates an Overweight rating on American Tower's shares.
11/09/17
ARGS
11/09/17
NO CHANGE
Target $170
ARGS
Buy
American Tower price target raised to $170 from $150 at Argus
Argus analyst Jacob Kilstein raised his price target on American Tower to $170 and kept his Buy rating. Kilstein says the company stands out among tower operators based on its margins, FFO growth rates, and high-quality assets, while also noting its international expansion steps. Additionally, the analyst says that the company stands to benefit from receding risks of telecom industry consolidation, as evidenced by the 6% jump in stock price when Sprint (S) and T-Mobile (TMUS) announced an end of their merger talks.
YY YY
$100.96

0.28 (0.28%)

08/30/17
GSCO
08/30/17
INITIATION
Target $101
GSCO
Buy
YY initiated with a Buy at Goldman Sachs
Goldman Sachs analyst Fan Liu started YY with a Buy rating and $101 price target, saying it is expected that the early pioneer in live streaming can sustain its leadership position.
11/16/17
JPMS
11/16/17
UPGRADE
Target $140
JPMS
Overweight
YY upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Alex Yao upgraded YY to Overweight and raised his price target for the shares to $140 from $70. The analyst is more positive on the company's earnings sustainability due to consistent user growth and improvement in live broadcasting monetization since Q2. He believes both YY Live and game broadcasting will continue to gain usage and improve monetization in 2018.
10/02/17
BOFA
10/02/17
NO CHANGE
Target $101
BOFA
Buy
YY price target raised to $101 from $89 at BofA/Merrill
BofA/Merrill analyst Kash Rangan raised YY's price target to $101 from $89 due to better Huya traffic trends and increased confidence heading into Q3 from YY's new social features. The analyst has a Buy rating on shares.
11/15/17
JEFF
11/15/17
UPGRADE
Target $110
JEFF
Buy
YY upgraded to Buy from Hold at Jefferies
Jefferies analyst Karen Chan upgraded YY to Buy and raised her price target for the shares to $110 from $79. Following the Q3 beat and "strong" Q4 outlook, the analyst is encouraged by signs of traction in YY's social strategy and new features. She expects the new app version launched in late September to drive improving user engagement and monetization.
CA CA Technologies
$33.30

0.08 (0.24%)

10/06/17
NOMU
10/06/17
NO CHANGE
Target $275
NOMU
Buy
Nomura Instinet lays out potential takeover targets for Broadcom
With revenues this year on track to reach $17B, few opportunities in the semiconductor space exist that would move the needle for Broadcom Limited (AVGO), Nomura Instinet analyst Romit Shah tells investors in a research note. As a result, the analyst believes the company could be looking to acquire companies in peripheral spaces. Shah's analysis yields CA Technologies (CA), NetApp (NTAP), Juniper (JNPR), Garmin (GRMN), Trimble (TRMB), Akamai (AKAM), F5 Networks (FFIV), Ciena (CIEN) and EchoStar (SATS) as possible takeover targets. The analyst thinks Broadcom shares may continue to "languish" in the near term given uncertainty with the Brocade acquisition and iPhone supply constraints. Shah, however, remains optimistic in Broadcom's ability to generate $20-plus in earnings per share in the future. He keeps a Buy rating on the shares with a $275 price target.
06/28/17
SBSH
06/28/17
NO CHANGE
Target $36
SBSH
Neutral
Citi sees 60% chance of CA buyout at $38 per share
Citi analyst Walter Pritchard believes the potential takeout of CA Technologies by privately held BMC has "significant strategic and financial merits." The analyst raised his price target for CA to $36 from $34, which factors in a 60% chance of an acquisition at $38 per share. He keeps a Neutral rating on CA.
06/28/17
BERN
06/28/17
NO CHANGE
BERN
Potential CA Technologies deal could face regulatory hurdle, says Bernstein
Bernstein analyst Mark L. Moerdler says that a potential acquisition of CA (CA) by BMC could be delayed and possibly blocked because the two companies are the largest and third largest IT Operations Management Mainframe Tools vendors, with a combined 52% of the market. The analyst says that a regulatory review of the transaction could cause "continuing disruption" of CA's business. He keeps a $28 price target and an Undeprerform rating on the stock.
09/18/17
KEYB
09/18/17
INITIATION
KEYB
Sector Weight
CA Technologies resumed with a Sector Weight at KeyBanc
KeyBanc analyst Alex Kurtz resumed coverage of CA Technologies with a Sector Weight rating. The current valuation is near the high end of the historical range while declines in the legacy solutions business will likely remain a drag, the analyst contends.
CSCO Cisco
$37.41

0.1 (0.27%)

12/05/17
MSCO
12/05/17
INITIATION
Target $28
MSCO
Overweight
Bandwidth initiated with an Overweight at Morgan Stanley
Morgan Stanley analyst Meta Marshall started Bandwidth (BAND) with an Overweight rating, calling the company unusual in the communications space since it owns both a software platform and the underlying nationwide IP voice network. Marshall, who thinks the market is underappreciating how compelling Bandwidth's value proposition could be, particularly with larger customers like Google (GOOG), Microsoft (MSFT), Amazon (AMZN) and Cisco (CSCO), set a $28 price target on Bandwidth shares.
12/05/17
OPCO
12/05/17
NO CHANGE
OPCO
Red Hat, VMware 'most important' to future architectures, says Oppenheimer
Oppenheimer analyst Ittai Kidron notes that he attended Amazon Web Services' re:Invent user conference where he conducted a user survey regarding future adoption of public cloud services. The analyst points out that according to the survey, long-term IT architecture plans are tilted heavily toward the public cloud as opposed to a more balanced hybrid cloud approach, the next three years are likely to be a key inflection point for data and applications transfer to the public cloud, and on-premise IT infrastructure vendors are likely to face pressures as the move to public cloud occurs. Within his coverage, users pointed to Red Hat (RHT)/VMware (VMW) as most important to future architectures, with Cisco (CSCO) making progress. Meanwhile, Citrix (CTXS)/HP Enterprise (HPE)/IBM(IBM)/NetApp (NTAP) seem most challenged, Kidron adds.
11/16/17
BMOC
11/16/17
NO CHANGE
Target $36
BMOC
Market Perform
Cisco price target raised to $36 from $32 at BMO Capital
BMO Capital analyst Tim Long raised his price target on Cisco to $36 and kept his Market Perform rating following Q1 results. Long says that while the slightly better outlook portends a return to growth amid an increase in recurring revenue base, the company continues to face challenges in its routing and enterprise verticals. The analyst anticipates the routing segment to continue experiencing headwinds as network architecture changes and increased competition weigh on demand.
11/22/17
UBSW
11/22/17
NO CHANGE
Target $15
UBSW
Neutral
Whitman departure a marketing negative for HP Enterprise, says UBS
UBS analyst Steven Milunovich noted HP Enterprise (HPE) reported a slight beat for Q4 despite fundamentals remaining mixed. The analyst believes CEO Meg Whitman's departure is a marketing negative and that Dell and Cisco (CSCO) are better positioned to serve on-premises computing needs. He also noted 2018 earnings will be back-end loaded and the stock appears fairly valued while lacking a catalyst. Milunovich maintained his Neutral rating and $15 price target on HP Enterprise shares.
FICO Fair Isaac
$155.57

-0.02 (-0.01%)

10/12/17
WBLR
10/12/17
NO CHANGE
WBLR
Outperform
Fair Isaac remains one of William Blair's favorite stocks
William Blair analyst Adam Klauber believes that with the company's longer-term investment period in its software products largely finished, Fair Isaac's (FICO) revenue growth should increase from 5% to high single digits over the next few years. The stock's recent strength likely reflects its modest exposure to Equifax (EFX) and anticipation of a strong Q4, Klauber tells investors in a research note. He says his estimates out to 2020 suggest 20% upside to the stock in his base scenario and up to 55% upside in his bull scenarios. The analyst adds that Fair Isaac remains one of his firm's favorite names.
08/01/17
WELS
08/01/17
NO CHANGE
WELS
Fair Isaac price target raised to $160 from $150 at Wells Fargo
After Fair Isaac reported weaker than expected Q3 results, Wells Fargo blames the miss on a year-over-year decline in its license fee revenue on a "difficult comp." The firm says that the company's results were "very strong" other than new license revenue. It thinks that the company's positive catalysts, including multiple new business wins, leave it poised for "growth acceleration, margin expansion and stock price appreciation." Wells raised its price target on the shares to $160 from $150 and keeps an Outperform rating on the stock.
T AT&T
$36.11

-0.44 (-1.20%)

11/29/17
KEYB
11/29/17
NO CHANGE
KEYB
Q3 results, analysis of Q4 viewership trends show some bright spots, says KeyBanc
KeyBanc analyst Andy Hargreaves notes that the Department of Justice's decision to sue to block AT&T (T)/Time Warner (TWX) seems likely to halt additional M&A until a resolution is reached. Additionally, the analyst points out that Q4 viewership trends appear most positive for Discovery (DISCA), Viacom (VIAB) so far, and 21st Century Fox (FOXA) remains his favorite long among TV network stocks.
11/21/17
CHLM
11/21/17
NO CHANGE
Target $114
CHLM
Buy
Dycom price target raised to $114 from $90 at Craig-Hallum
Craig-Hallum analyst Christian Schwab raised his price target for Dycom (DY) to $114 from $90 following quarterly results and as the worst of AT&T's (T) spending moderation seems behind it. The analyst reiterates a Buy rating on Dycom's shares.
12/04/17
JEFF
12/04/17
NO CHANGE
Target $194
JEFF
Hold
Jefferies sees Aetna trading at 10% discount to deal price
Jefferies analyst David Windley sees Aetna (AET) trading at a 10% spread to the $207 per share price paid by CVS Health (CVS) given the deal's "regulatory hurdles." The analyst sees Aetna trading today to $186 per share. Aetna in premarket trading is up 3%, or $5.99, to $187.30. Windley raised his price target for the stock to $194 from $185 and keeps a Hold rating on the name. The Department of Justice's stance on another major vertical integration, AT&T's (T) acquisition of Time Warner (TWX), suggests the CVS, Aetna transaction could face "significant scrutiny," Windley tells investors in a research note. He believes the regulatory cycle will likely take 9-12 months and may require some Part D divestitures.
ORBK Orbotech
$49.28

-0.16 (-0.32%)

11/02/17
OPCO
11/02/17
NO CHANGE
Target $54
OPCO
Outperform
Orbotech price target raised to $54 from $42 at Oppenheimer
Oppenheimer analyst Andrew Uerkwitz raised his price target for Orbotech to $54 from $42 following quarterly results. The analyst reiterates an Outperform rating on the shares.
11/07/17
NEED
11/07/17
NO CHANGE
Target $65
NEED
Buy
Orbotech price target raised to $65 from $54 at Needham
Needham analyst James Ricchiuti raised his price target on Orbotech to $65 following yesterday's investor day, saying the management has laid out a compelling long-term growth story supported by positive "megatrends" in the electronics industry. The analyst is keeping his Buy rating, saying his near-term view is also positive amid "some of the strongest short-term market conditions in its long history as a leading supplier of PCB and FPD equipment."
08/31/17
STFL
08/31/17
INITIATION
Target $46
STFL
Buy
Orbotech initiated with a Buy at Stifel
Stifel analyst Patrick Ho started Orbotech with a Buy rating and $46 price target saying the company has a diversified product portfolio with "multiple" growth drivers.
11/07/17
LEHM
11/07/17
NO CHANGE
Target $60
LEHM
Overweight
Orbotech price target raised to $60 from $54 at Barclays
Barclays analyst Joseph Wolf raised his price target for Orbotech to $60 after the company hosted its first annual investor day. The analyst views the company's outlook as bullish with 2020 earnings per share potential of over $5.00. He keeps an Overweight rating on the shares.
INTU Intuit
$156.19

1.72 (1.11%)

11/21/17
OPCO
11/21/17
NO CHANGE
Target $166
OPCO
Outperform
Intuit price target raised to $166 from $159 at Oppenheimer
Oppenheimer analyst Scott Schneeberger raised his price target for Intuit to $166 from $159 following quarterly results. The analyst reiterates an Outperform rating on the shares.
11/21/17
WELS
11/21/17
NO CHANGE
Target $180
WELS
Outperform
Intuit price target raised to $180 from $163 at Wells Fargo
Wells Fargo analyst Siti Panigrahi raised his price target for Intuit to $180 from $163 following quarterly results. The analyst reiterates an Outperform rating on the shares.
11/21/17
DBAB
11/21/17
NO CHANGE
Target $170
DBAB
Buy
Intuit price target raised to $170 from $160 at Deutsche Bank
Deutsche Bank analyst Nandan Amladi raised his price target for Intuit to $170 citing "solid execution and runway for continued growth" following last night's Q1 results. The analyst views the annual guidance as conservative and says he remains a buyer of the stock.
11/21/17
JEFF
11/21/17
NO CHANGE
Target $185
JEFF
Buy
Intuit price target raised to $185 from $157 at Jefferies
Jefferies analyst Brent Thill raised his price target for Intuit to $185 saying the company last night posted a "nice beat for the seasonally small" Q1 quarter. The analyst believes products like TurboTax Live, Intuit Turbo, and QuickBooks Capital can drive revenue synergies across all major segments for the medium term. He maintains a Buy rating on Intuit shares.
SPLK Splunk
$80.45

2.44 (3.13%)

11/17/17
RBCM
11/17/17
NO CHANGE
Target $90
RBCM
Outperform
Splunk price target raised to $90 from $76 at RBC Capital
RBC Capital analyst Matthew Hedberg raised his price target on Splunk to $90, saying the beat in Q4 earnings was "inflection" type. Hedberg notes the company's quarter saw success across its geographies and verticals, along with strength seen in the cloud, security, and license revenue. The analyst adds that he is bullish on the company's ability to grow its market share, keeping his Outperform rating on Splunk.
11/17/17
FBNS
11/17/17
NO CHANGE
FBNS
Outperform
Splunk price target raised to $90 from $80 at FBN Securities
FBN Securities analyst Shebly Seyrafi raised his price target for Splunk to $90 and reiterates an Outperform rating on the shares citing last night's "strong" Q3 results.
11/20/17
BARD
11/20/17
NO CHANGE
Target $85
BARD
Outperform
Splunk price target raised to $85 from $75 at Baird
Baird analyst Rob Oliver raised his price target on Splunk to $85 from $75 following Q3 results. The analyst cited its raised guidance and the company's strength driven by new customers, increased average selling prices at existing customers, on premise business, and cloud transactions. Olive reiterated his Outperform rating on Splunk shares.
11/27/17
SBSH
11/27/17
NO CHANGE
Target $73
SBSH
Neutral
Splunk outlook well below consensus without ASC 606 impact, says Citi
Citi analyst Walter Pritchard believes Splunk's fiscal 2019 revenue guidance excluding the Accounting Standards Codification 606 impact is well below the consensus. Citing his estimates and management's commentary at analyst day, Pritchard sees the impact on revenue from the accounting change at $100M-plus and the corresponding impact on operating margin at 200 basis points, which he notes is the entire year-over-year margin expansion currently included in the guidance. Splunk shares rallied "substantially more than deserved" on the Q3 earnings report because of perceived strength in the guidance, Pritchard told investors earlier in a research note. The analyst believes more than all the "better" fiscal 2019 guidance is due to ASC 606. He keeps a Neutral rating on Splunk with a $73 price target. The stock in early trading is down 2c to $84.08.
XLNX Xilinx
$68.39

-0.03 (-0.04%)

10/06/17
MKMP
10/06/17
NO CHANGE
Target $78
MKMP
Neutral
Xilinx price target raised to $78 from $63 at MKM Partners
MKM Partners analyst Ruben Roy raised his price target on Xilinx (XLNX) to $78 from $63, noting that recent conversations with the company indicate healthy demand trends. The analyst added that the feedback related to the Industrial and Aerospace/Defense markets was especially positive, even as communications infrastructure space will remain mixed for the rest of FY17. Competitive dynamics will also remain favorable, with Intel (INTC) unlikely to gain any meaningful market share, added Roy, who kept his Neutral rating on Xilinx shares.
10/26/17
JEFF
10/26/17
NO CHANGE
Target $80
JEFF
Buy
Xilinx selloff on earnings a buying opportunity, says Jefferies
Jefferies analyst Mark Lipacis tells investors to buy Xilinx (XLNX) on today's post-earnings pullback. The analyst believes the selloff after a "beat and raise" quarter shows sentiment was too high into the print. He continues to believe Xilinx has both a hardware and software lead over Intel (INTC). The analyst raised his price target for the shares to $80 from $78 and keeps a Buy rating on the name.
07/27/17
07/27/17
NO CHANGE
Target $40

Reduce
Xilinx shares remain overvalued, says Nomura Instinet
Nomura Instinet analyst Romit Shah believes Xilinx continues to under-deliver on operating expenses as the quarter and guidance were higher than expected. He believes consensus is preoccupied with unproven markets such as AI and autonomous driving and are ignoring the lack of momentum in the core business. Shah believes Xilinx shares remain overvalued and reiterates his Reduce rating and $50 price target.
07/18/17
LEHM
07/18/17
UPGRADE
Target $60
LEHM
Equal Weight
Xilinx upgraded to Equal Weight from Underweight at Barclays
Barclays analyst Blayne Curtis upgraded Xilinx (XLNX) to Equal Weight saying he sees more downside elsewhere in the U.S. Semiconductors space. The analyst raised his price target for the shares to $60 from $53. The analyst this morning downgraded both AMD (AMD) and Cirrus Logic (CRUS) to Underweight.
AQ Aquantia
$10.98

0.09 (0.83%)

11/28/17
MSCO
11/28/17
INITIATION
Target $15
MSCO
Overweight
Aquantia initiated with an Overweight at Morgan Stanley
Morgan Stanley analyst Joseph Moore initiated Aquantia with an Overweight rating and $15 price target, predicting the company can grow at a rate of over 20% for multiple years as "multigig" Ethernet technology moves into the mainstream.
11/28/17
RAJA
11/28/17
INITIATION
Target $15
RAJA
Outperform
Aquantia initiated with an Outperform at Raymond James
Raymond James analyst Chris Caso initiated Aquantia with an Outperform and $15 price target. The analyst believes Aquantia has first mover advantage for an upcoming Ethernet product cycle based on a standard they developed, with challenging technology, and limited competition. Caso views shares as attractively valued and sees some optionality from new products and attractiveness as an acquisition target.
11/28/17
NEED
11/28/17
INITIATION
Target $15
NEED
Buy
Aquantia initiated with a Buy at Needham
Needham analyst N. Quinn Bolton initiated Aquantia with a Buy rating and a price target of $15. Bolton says the company is a market leader in Multi-Gig Ethernet technology and will benefit from the upgrade cycle to higher speed line rates. Over the longer term, the analyst also notes that Aquantia is well positioned for the adoption of that technology in the automotive segment as well as the use of its QuantumStream single-lane 100G over copper technology in hyperscale data centers.
11/28/17
11/28/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Loxo Oncology (LOXO) initiated with an Outperform at William Blair. 2. Aquantia (AQ) initiated with a Buy at Needham and Deutsche Bank, an Outperform at Raymond James, as well as an Overweight at Morgan Stanley and Barclays. 3. Mirna Therapeutics (MIRN) initiated with an Outperform at Wedbush. 4. Select Energy Services (WTTR) resumed with an Outperform at Wells Fargo. 5. Nexa Resources (NEXA) initiated with an Outperform at Credit Suisse. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
APPN Appian
$21.20

0.06 (0.28%)

10/02/17
COWN
10/02/17
DOWNGRADE
Target $23
COWN
Market Perform
Appian downgraded to Market Perform at Cowen
As previously reported, Cowen analyst Gregg Moskowitz downgraded Appian to Market Perform from Outperform based on valuation. He remains constructive on the company's low code opportunity but also believes it is being captured by the company's current valuation. Moskowitz raised his price target to $23 from $21 on Appian shares.
11/21/17
RHCO
11/21/17
INITIATION
Target $28
RHCO
Buy
Appian initiated with a Buy at SunTrust
SunTrust analyst Terry Tillman initiated Appian with a Buy rating and a price target of $28. As a cloud-based platform for building custom enterprise apps, the analyst writes in his research note, Appian offers investors exposure to a $29B market, adding that the company benefits from a differentiated low-code software development platform with the benefits of simplicity and rapid deployment time. Tillman notes that while Appian may see operating losses and negative cash flows in 2018, this is mitigated by the expected 30% or more growth of subscription revenue.
10/02/17
COWN
10/02/17
DOWNGRADE
COWN
Market Perform
Appian downgraded to Market Perform from Outperform at Cowen
11/27/17
WBLR
11/27/17
INITIATION
WBLR
Outperform
Appian initiated with an Outperform at William Blair
William Blair analyst Bhavan Suri started Appian with an Outperform rating.
DSGX Descartes Systems
$26.45

-0.25 (-0.94%)

11/30/17
ADAM
11/30/17
NO CHANGE
Target $34
ADAM
Buy
Descartes Systems well positioned, but stock getting expensive, says Canaccord
Canaccord analyst David Hynes noted Descartes Systems reported another set of solid results and believes the company remains well positioned to execute. The analyst acknowledged its valuation is approaching the high end of a range that he can rationally argue that investors should buy the stock. He raised his price target to $34 from $30 on the stock, which is about as high as he can justify unless the numbers move materially higher. Hynes reiterated his Buy rating on Descartes Systems shares.
11/30/17
RAJA
11/30/17
DOWNGRADE
RAJA
Market Perform
Descartes Systems downgraded to Market Perform from Outperform at Raymond James
Raymond James analyst Steven Li downgraded Descartes Systems to Market Perform on valuation and said organic growth needs to improve for shares to re-rate further.
06/01/17
ADAM
06/01/17
NO CHANGE
Target $28
ADAM
Buy
Descartes Systems an expensive stock at current levels, says Canaccord
Canaccord analyst David Hynes called Descartes Systems an expensive stock and said it was OK to buy here but he would be more aggressive on pullbacks. Hynes said the Descartes business is excellent and his view on the company remains positive. Hynes reiterated his Buy rating and raised his price target to $28 from $26 on Descartes Systems shares.
BOX Box
$20.50

0.15 (0.74%)

09/25/17
09/25/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. General Motors (GM) upgraded to Buy from Hold at Deutsche Bank with analyst Rod Lache saying GM's autonomous vehicles will be ready for commercial deployment, without human drivers, much sooner than widely expected and possibly years ahead of competitors. 2. Ross Stores (ROST) upgraded to Overweight from Neutral at JPMorgan with analyst Matthew Boss saying he left meetings with management more positive on the off-price sector and believes the company is well positioned for double-digit growth. 3. Under Armour (UA, UAA) upgraded to Overweight from Sector Weight at KeyBanc with analyst Edward Yruma saying the addition of a new chief operating officer along with a renewed focus on improving financial performance point to a near-term inflection for the shares. 4. Transocean (RIG) upgraded to Buy from Neutral at UBS with analyst Angie Sedita citing "early signs of a slow recovery." 5. Box (BOX) upgraded to Outperform from Market Perform at Raymond James with analyst Brian Peterson saying risk/reward is compelling at current levels. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/13/17
COWN
10/13/17
NO CHANGE
Target $25
COWN
Outperform
Following BoxWorks conference, Box set up looks 'compelling,' says Cowen
Cowen analyst Richard Davis said Box has a compelling set up that could lead to gains exceeding 50% over the next two years. He noted its recent BoxWorks conference where the company announced products and partnerships that enhance collaboration with Box, added technologies to simplify the creation of content driven business work flows, and bring intelligence to enterprise content with AI and machine learning. Davis reiterated his Outperform rating and raised his price target to $25 from $24 on Box shares.
11/30/17
ADAM
11/30/17
NO CHANGE
Target $25
ADAM
Buy
Box weakness a buying opportunity, says Canaccord
Canaccord analyst Richard Davis noted Box shares sold off following its Q3 earnings report as investors chose to lock in profits after its run this year. The analyst believes the stock reaction is "overwrought" given its results and guidance and he would be a buyer as he believes the shares should rally back. Davis reiterated his Buy rating and $25 price target on Box shares.
11/30/17
JMPS
11/30/17
NO CHANGE
Target $25
JMPS
Outperform
Box price target raised to $25 from $22 at JMP Securities
JMP Securities analyst Greg McDowell said that despite Box's "disappointing" big deal metrics the company reported a "solid" quarter overall. He blames the company's big deal commentary and Q4 guidance that bracketed consensus for the afterhours weakness in the stock, though he continues to recommend Box shares given the company's long runway for growth, weakening competition and leverage in its model. McDowell raised his price target on the stock to $25 after earnings and keeps an Outperform rating on Box shares.
JCOM j2 Global
$74.85

-0.36 (-0.48%)

01/25/17
SBSH
01/25/17
DOWNGRADE
Target $88
SBSH
Neutral
j2 Global downgraded to Neutral from Buy at Citi
Citi analyst Walter Pritchard downgraded j2 Global (JCOM) to Neutral citing valuation. The analyst believes the shares at current levels reflect the Everyday Health (EVDY) accretion potential. He keeps an $88 price target for the j2.
05/09/17
JMPS
05/09/17
NO CHANGE
JMPS
j2 Global outlook remains positive despite miss, says JMP Securities
After j2 Global reported weaker than expected Q1 results, JMP Securities analyst Rishi Jaluria says that the results were "solid." The analyst continues to be upbeat on the company's M&A and investment strategies, and he thinks that its margins can rise further. He keeps a $105 price target and an Outperform rating on the shares.
05/09/17
SUSQ
05/09/17
NO CHANGE
Target $120
SUSQ
Positive
j2 Global price target raised to $120 from $95 at Susquehanna
Susquehanna analyst Shyam Patil raised his price target on j2 Global to $120 from $95 following Q1 results. The analyst said the company's earnings appear to be tracking ahead of the mid-point of guidance, they continue to extract synergies from its EVDY acquisition, and he believes numbers are poised to go up. Patil reiterated his Positive rating on j2 Global shares.
ZAYO Zayo Group
$34.11

-0.31 (-0.90%)

08/22/17
STFL
08/22/17
NO CHANGE
STFL
Zayo Group shares should be bought on weakness, says Stifel
After Zayo reported slightly weaker than expected Q4 results, Stifel analyst Matthew Heinz says that the company's "bookings, cash flow, and capital efficiency" all improved, leaving him positive about its results. The analyst says that the company is "moving in the right direction" despite "the headline miss" and he recommends buying the shares on weakness.
08/28/17
DBAB
08/28/17
INITIATION
Target $36
DBAB
Hold
Zayo Group initiated with a Hold at Deutsche Bank
Deutsche Bank analyst Matthew Niknam started Zayo Group with a Hold rating and $36 price target. The analyst cites execution concerns and "lack of clarity on meaningful near-term inflections" for his neutral stance.
10/17/17
UBSW
10/17/17
INITIATION
Target $45
UBSW
Buy
Zayo Group initiated with a Buy at UBS
UBS analyst John Hodulik started Zayo Group with a Buy rating and $45 price target, identifying growth in streaming video, cloud and big data analytics "three ways to win" with the provider of bandwidth infrastructure.
07/17/17
WELS
07/17/17
NO CHANGE
WELS
Outperform
Wells says Crown Castle $7B deal would provide attractive comp for Zayo
Wells Fargo analyst Jennifer Fritzsche noted the Reuters report that claims Crown Castle (CCI) has bid in the $7B range for Lightower Fiber Networks. She added the news is not surprising to her given how aggressive Crown Castle has been in building its fiber portfolio, which is a strategy with which she agrees. She believes such an acquisition would provide an attractive comp for Zayo Group (ZAYO), as she noted that Lightower is growing top line at a much faster rate but Zayo covers triple the geography. Fritzsche keeps Outperform ratings on Crown Castle and Zayo Group.
WDAY Workday
$102.35

3.15 (3.18%)

11/29/17
MUFG
11/29/17
NO CHANGE
Target $125
MUFG
Overweight
Workday price target raised to $125 from $116 at MUFG
MUFG analyst Stephen Bersey raised his price target for Workday to $125 following tonight's better than expected Q3 results. The shares in after-hours trading dropped 5%, or $5.54, to $101.00. The company had another strong quarter, growing its high-margin subscription at 37% on a year-over-year basis, Bersey tells investors in a post-earnings research note. He sees Workday's subscription momentum continuing and reiterates an Overweight rating on the shares.
11/30/17
BARD
11/30/17
NO CHANGE
Target $114
BARD
Outperform
Workday fundamentals better than noise suggests, says Baird
Baird analyst Mark Macon expects near-term weakness in Workday following its Q3 results. The analyst said Q4 guidance exceeded estimates but the combination of optics and perhaps sector rotation had the shares weak following its report. He believes the long-term fundamentals remain intact and recommends accumulation on the weakness. Macon reiterated his Outperform rating and $114 price target on Workday shares.
11/30/17
NEED
11/30/17
NO CHANGE
NEED
Hold
Workday billings slowdown and light Q1 outlook may cap stock gains, says Needham
Needham analyst Scott Berg is keeping his Hold rating on Workday after Q3 earnings. Berg says that while Workday's revenue was "solid" and deal commentary was "better than expected", he believes the appreciation in the stock price may pause based on the company's slowing net new Annual Contract Value and billings, along with lighter-than-expected Q1 subscription guidance.
11/30/17
SBSH
11/30/17
NO CHANGE
Target $85
SBSH
Sell
Workday growth trajectory still uncertain, says Citi
Citi analyst Walter Pritchard sees "plenty of head-scratching" after Workday's Q3 billings growth of 25% missed the consensus estimate of 28%. The analyst calculates the Q3 bookings growth at just 5% year-over-year, using new 606 backlog metrics. He says he's left "without a clear leading / coincident indicator of growth" and that his analysis suggests Workday's revenue growth will continue to slow. Pritchard raised his price target for the shares to $85 from $72 and keeps a Sell rating on Workday.
OTEX OpenText
$32.18

-0.27 (-0.83%)

07/26/17
PIPR
07/26/17
DOWNGRADE
Target $7.1
PIPR
Neutral
Guidance Software downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst Andrew Nowinski downgraded Guidance Software (GUID) to Neutral and lowered his price target for the shares to $7.10 from $8.50 after the company agreed to be acquired by OpenText (OTEX).
11/22/17
MACQ
11/22/17
DOWNGRADE
Target $31.5
MACQ
Underperform
OpenText downgraded to Underperform from Neutral at Macquarie
Macquarie analyst Gus Papageorgiou downgraded OpenText to Underperform and lowered its price target to $31.50 from 34.50. The analyst said OpenText has highly recurring and profitable operations but poor returns on capital and limited growth due to a leveraged balance sheet.
07/27/17
RILY
07/27/17
DOWNGRADE
Target $7.1
RILY
Neutral
Guidance Software downgraded to Neutral from Buy at B. Riley
B. Riley analyst Kevin Liu downgraded Guidance Software (GUID) to Neutral and lowered his price target for the shares to $7.10 from $9 after the company agreed to be acquired by OpenText (OTEX).
11/22/17
RAJA
11/22/17
NO CHANGE
Target $40
RAJA
Outperform
Raymond James remains bullish on OpenText despite competitor downgrade
Raymond James analyst Steven Li notes that a competitor downgraded OpenText this morning to an Underperform rating, saying Constellation Software has a much stronger balance sheet. The analyst argues that it is "stating the obvious," given that OpenText just made the largest acquisition in its history. This logic does not hold historically, he notes. While Li acknowledges that Constellation Software has much higher return on capital, and may have better growth and cash return prospects, he points out that its competitor report does not highlight the recent turn in organic growth. The analyst reiterates an Outperform rating and $40 price target on OpenText's shares.
ELLI Ellie Mae
$88.50

2.14 (2.48%)

10/18/17
RBCM
10/18/17
UPGRADE
RBCM
Outperform
Ellie Mae upgraded to Outperform from Sector Perform at RBC Capital
09/01/17
JPMS
09/01/17
NO CHANGE
Target $112
JPMS
Overweight
Ellie Mae acquisition positive, but Harvey a headwind, says JPMorgan
JPMorgan analyst Sterling Auty views Ellie Mae's acquisition of Velocify positively. The deal should build the company's subscription revenue opportunity at a time when mortgage lenders are shifting more attention to home purchase mortgages relative to refinances, Auty tells investors in a research note. The analyst, however, views Hurricane Harvey as a headwind. He lowered his non-contracted revenue estimates for Ellie by $1M in both Q3 and Q4 to account for a potential significant slowdown in the Houston housing market. Auty keeps an Overweight rating on the shares.
09/13/17
OPCO
09/13/17
NO CHANGE
Target $101
OPCO
Outperform
Ellie Mae recent selloff provides buying opportunity, says Oppenheimer
Oppenheimer analyst Brian Schwartz believes the recent sell-off in Ellie Mae provides investors with an opportunity to buy a category leader at an attractive valuation. The analyst notes that the company's momentum in bookings, customer acquisition, and loan volumes remains healthy, and its technology leadership in the market will extend in 4Q from new tech announcements and the Velocify closing. He reiterates an Outperform rating and $101 price target on the shares.
10/18/17
RBCM
10/18/17
UPGRADE
Target $105
RBCM
Outperform
Ellie Mae upgraded to Outperform at RBC Capital on expected revenue growth
As previously reported, RBC Capital analyst Ross MacMillan upgraded Ellie Mae to Outperfrom from Sector Perform and raised his price target to $105 from $90. MacMillan says the risk-reward on the stock is favorable, forecasting accelerating revenue in 2018 due to price increases and growing seat activations. The analyst also expects the next platform version to drive higher revenue per loan and more operating leverage in 2019 and beyond.
NOW ServiceNow
$117.76

1.56 (1.34%)

11/09/17
UBSW
11/09/17
INITIATION
Target $168
UBSW
Buy
ServiceNow assumed with a Buy at UBS
UBS analyst Jennifer Swanson Lowe assumed coverage of ServiceNow with a Buy rating and raised her price target for the shares to $168 from $128. ServiceNow currently offers the best mix of growth and margins in the software group, the analyst contends.
11/06/17
PIPR
11/06/17
NO CHANGE
Target $150
PIPR
Overweight
ServiceNow shares have 20%-60% upside over next year, says Piper Jaffray
After taking a "deep dive" on the company's new annual contract value bookings, Piper Jaffray analyst Alex Zukin says ServiceNow shares have 20%-60% upside over the next 12 months based on bull and base case scenarios. The company's initial 2018 subscription revenue guidance should come in at or above the consensus expectations of up 33% and "continue to be walked up from there," Zukin tells investors in a research note. He believes ServiceNow's near-term, medium-term and long-term setup is favorable. The analyst raised his price target for the shares to $150 from $140 and reiterates an Overweight rating on the name.
10/27/17
ARGS
10/27/17
NO CHANGE
ARGS
ServiceNow price target raised to $150 from $125 at Argus
Argus analyst Joseph Bonner raised his price target on ServiceNow to $150 from $125 and maintained a Buy rating following another strong quarter for the company in Q3. Bonner believes ServiceNow's stock is favorably valued by historical standards, and sees solid profit and revenue outlook over the next few years.
11/09/17
UBSW
11/09/17
DOWNGRADE
Target $95
UBSW
Sell
Workday assumed with a Sell from Buy at UBS
UBS analyst Jennifer Swanson Lowe double downgraded Workday (WDAY) to Sell from Buy and lowered her price target for the shares to $95 from $121 after assuming coverage of the name. The analyst expects subscription revenue growth of 25%-30%, but sees increasing headwinds in human resource software and limited near-term revenue benefit from Financials. The stock is pricing in expectations for both high growth and profitability that may prove difficult to meet, Lowe tells investors in a research note. The analyst prefers shares of ServiceNow (NOW).
XRX Xerox
$29.64

0.2 (0.68%)

10/03/17
UBSW
10/03/17
INITIATION
Target $36
UBSW
Neutral
Xerox initiated with a Neutral at UBS
UBS analyst Steven Milunovich started Xerox with a Neutral rating and $36 price target. The analyst believes Xerox "is in the sweet spot of the turnaround" now, but is more bearish on the company longer term. He believes Xerox will have difficulty building a presence in the printer market over the long term.
10/03/17
10/03/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Xerox (XRX) initiated with a Neutral at UBS. 2. United Rentals (URI) reinstated with a Hold at Deutsche Bank. 3. Home Depot (HD) initiated with a Buy at Gordon Haskett. 4. TD Ameritrade (AMTD) reinstated with a Neutral at Goldman Sachs. 5. West Pharmaceutical (WST) initiated with an Equal Weight at Stephens. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
12/05/17
UBSW
12/05/17
NO CHANGE
Target $35
UBSW
Neutral
Xerox Q4 results could lift stock, says UBS
UBS analyst Steven Milunovich noted when he initiated coverage on Xerox shares he expected positive catalysts in the near-term, including new management and cost savings. He also notes the stock reacted poorly to Q3 results, which he believes was an overreaction. The analyst said shares could react better following Q4 results as it could include better margins, positive seasonality, and cost savings. Milunovich maintained his Neutral rating and $34.50 price target on Xerox shares.
08/02/17
SBSH
08/02/17
NO CHANGE
Target $39
SBSH
Buy
Citi sees 'big positive turn' at Xerox, ups target to $39
Xerox is a "making a big positive turn" as it remains on track for its cost saving and operating margin improvements while its new leadership team is "starting to regain investor credibility," Citi analyst Jim Suva tells investors in a research note. The analyst expects revenue declines to moderate in the second half of 2017 with new products launching mid-year. He views the valuation as attractive and upped his price target for the shares to $39 from $36. Suva reiterates a Buy rating on Xerox.

TODAY'S FREE FLY STORIES

LYV

Live Nation

$48.15

-0.53 (-1.09%)

17:46
08/17/18
08/17
17:46
08/17/18
17:46
Hot Stocks
Live Nation CFO discloses sale of 40K shares of common stock »

Live Nation CFO Elizabeth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$72.63

0.21 (0.29%)

, XLU

Utilities SPDR

$54.50

0.25 (0.46%)

17:40
08/17/18
08/17
17:40
08/17/18
17:40
General news
Week ending ETF Scorecard: Consumer Staples outperforms, Energy skids »

S&P500 SECTORS:…

XLE

Energy Select Sector SPDR

$72.63

0.21 (0.29%)

XLU

Utilities SPDR

$54.50

0.25 (0.46%)

IYR

DJ US Real Estate Index Fund

$83.16

0.765 (0.93%)

XLP

Consumer Staples Sector SPDR

$55.02

0.39 (0.71%)

XLY

Consumer Discretionary Sector SPDR

$112.51

0.11 (0.10%)

XLB

S&P Select Materials SPDR

$58.41

0.41 (0.71%)

XLF

Financial Select Sector

$28.16

0.055 (0.20%)

XLV

Health Care Select Sector SPDR

$91.12

0.33 (0.36%)

XLK

Technology Select Sector SPDR

$73.17

0.14 (0.19%)

XLI

Industrial Select Sector SPDR

$76.26

0.47 (0.62%)

GLD

SPDR Gold Trust

$112.12

1.01 (0.91%)

SLV

iShares Silver Trust

$13.93

0.16 (1.16%)

USO

United States Oil Fund

$13.70

0.065 (0.48%)

UNG

United States Natural Gas Fund

$24.18

0.295 (1.24%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$86.03

0.08 (0.09%)

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$115.97

0.11 (0.09%)

TLT

iShares 20+ Year Treasury Bond Fund

$120.99

0.16 (0.13%)

IEF

iShares 7-10 Year Treasury Bond ETF

$102.49

0.04 (0.04%)

SHY

iShares 1-3 Year Treasury Bond

$83.28

0.03 (0.04%)

IWD

iShares Russell 1000 Value

$126.16

0.6 (0.48%)

IWF

iShares Russell 1000 Growth

$150.80

0.27 (0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLD

SPDR Gold Trust

$112.12

1.01 (0.91%)

17:33
08/17/18
08/17
17:33
08/17/18
17:33
Hot Stocks
SPDR Gold Trust holdings fall to 772.24MT from 773.41MT »

This is the 5th…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GDOT

Green Dot

$85.04

0.37 (0.44%)

17:30
08/17/18
08/17
17:30
08/17/18
17:30
Hot Stocks
Green Dot exec Dent sells 7,754 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

SMSI

Smith Micro

$2.49

-0.01 (-0.40%)

17:17
08/17/18
08/17
17:17
08/17/18
17:17
Syndicate
Breaking Syndicate news story on Smith Micro »

Smith Micro files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDRA

ENDRA Life Sciences

$2.70

0.2 (8.00%)

17:14
08/17/18
08/17
17:14
08/17/18
17:14
Syndicate
Breaking Syndicate news story on ENDRA Life Sciences »

ENDRA Life Sciences files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$346.44

0.55 (0.16%)

17:10
08/17/18
08/17
17:10
08/17/18
17:10
Hot Stocks
Boeing awarded $152.5M U.S. Navy contract »

Boeing is awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$346.44

0.55 (0.16%)

17:09
08/17/18
08/17
17:09
08/17/18
17:09
Hot Stocks
Boeing awarded $217M Defense Department contract »

The Boeing Co has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LLL

L3 Technologies

$210.37

0.56 (0.27%)

17:08
08/17/18
08/17
17:08
08/17/18
17:08
Hot Stocks
L3 Technologies awarded $240M Defense Department contract »

L-3 Communications was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSGX

Histogenics

$2.65

-0.05 (-1.85%)

17:06
08/17/18
08/17
17:06
08/17/18
17:06
Syndicate
Breaking Syndicate news story on Histogenics »

Histogenics files $75M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLD

Prologis

$67.45

1.79 (2.73%)

, DCT

DCT Industrial

$68.77

1.805 (2.70%)

16:58
08/17/18
08/17
16:58
08/17/18
16:58
Conference/Events
DCT Industrial to host special shareholder meeting »

Special Shareholder…

PLD

Prologis

$67.45

1.79 (2.73%)

DCT

DCT Industrial

$68.77

1.805 (2.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WLK

Westlake Chemical

$95.61

-1.33 (-1.37%)

16:56
08/17/18
08/17
16:56
08/17/18
16:56
Hot Stocks
Westlake Chemical expands share repurchase program by $150M »

The Board of Directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 11

    Sep

SM

SM Energy

$27.38

0.17 (0.62%)

16:55
08/17/18
08/17
16:55
08/17/18
16:55
Recommendations
SM Energy analyst commentary at MUFG »

SM Energy price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

PENN

Penn National

$33.04

0.86 (2.67%)

16:51
08/17/18
08/17
16:51
08/17/18
16:51
Hot Stocks
Penn National CEO acquires 100,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$173.78

-0.98 (-0.56%)

16:49
08/17/18
08/17
16:49
08/17/18
16:49
Periodicals
U.S. wants Facebook to help wiretap Messenger for criminal probe, Reuters says »

The U.S. government is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 22

    Aug

  • 06

    Sep

  • 18

    Sep

WLK

Westlake Chemical

$95.61

-1.33 (-1.37%)

16:46
08/17/18
08/17
16:46
08/17/18
16:46
Hot Stocks
Westlake Chemical raises quarterly dividend 19% to 25c per share »

The dividend will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 11

    Sep

EAST

Eastside Distilling

$7.40

-0.01 (-0.13%)

16:45
08/17/18
08/17
16:45
08/17/18
16:45
Syndicate
Breaking Syndicate news story on Eastside Distilling »

Eastside Distilling files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOV

Spark Networks

$12.80

-0.095 (-0.74%)

16:44
08/17/18
08/17
16:44
08/17/18
16:44
Syndicate
Spark Networks files to sell 515,416 ordinary shares for holders »

Including 222 ordinary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AHPA

Avista Healthcare Public Acquisition Corp.

$10.12

(0.00%)

16:42
08/17/18
08/17
16:42
08/17/18
16:42
Hot Stocks
Avista Healthcare Public Acquisition Corp., Organogenesis announce combination »

Avista Healthcare Public…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCF

TCF Financial

$25.84

0.17 (0.66%)

16:41
08/17/18
08/17
16:41
08/17/18
16:41
Hot Stocks
TCF Financial COO sells 77,725 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LGF.A

Lionsgate

$22.95

-0.11 (-0.48%)

16:38
08/17/18
08/17
16:38
08/17/18
16:38
Recommendations
Lionsgate analyst commentary at Barrington »

Lionsgate price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

16:35
08/17/18
08/17
16:35
08/17/18
16:35
General news
Breaking General news story  »

Moody's cuts Turkey…

MSL

MidSouth Bancorp

$14.90

0.1 (0.68%)

16:32
08/17/18
08/17
16:32
08/17/18
16:32
Hot Stocks
MidSouth Bancorp says 'will carefully review' letter sent by Jacobs Asset Mgt. »

MidSouth Bancorp issued…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EME

EMCOR

$77.96

1.005 (1.31%)

16:31
08/17/18
08/17
16:31
08/17/18
16:31
Hot Stocks
Emcor CEO sells 23,434 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
08/17/18
08/17
16:30
08/17/18
16:30
Options
Preliminary option volume of 22.3M today »

Preliminary option volume…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.